article

European Pharmaceutical Review Issue 6 2021

This journal features articles discussing what knowledge could help the industry to prevent the next nitrosamine-like contamination event, the key steps when validating analytical techniques for cell and gene therapies and how artificial intelligence is shaping microbiology. Also in this issue, using Raman spectroscopy and hyperspectral imaging to detect counterfeit pharmaceuticals and recent developments in stress testing.

Issue 6 articles:

  • MANUFACTURING, PACKAGING & LOGISTICS
    Ways to promote patient access as a European healthcare priority
    Catherine Owen, Bristol Myers Squibb
  • BIOPROCESSING & BIOPRODUCTION
    The weakest link – biopharma workforce development
    Killian O’Driscoll, NIBRT
  • EVENT REVIEW
    European Pharmaceutical Review’s The Future of QA/QC for Complex Biologics Online Summit
  • FORMULATION, DEVELOPMENT & DELIVERY
    United efforts to accelerate drug development

    John Smyth, Axel Glasmacher and Jaap Verweij, CDDF

This issue also features our App Note Supplement with contributions from bioMérieux Industry, Charles River, Shimadzu, TA Instruments, Thermo Fisher Scientific and WITec.

Send this to a friend